References
- De Witt HamerPCSmall molecule kinase inhibitors in glioblastoma: a systematic review of clinical studiesNeuro Oncol20101230431620167819
- OhgakiHKleihuesPGenetic pathways to primary and secondary glioblastomaAm J Pathol20071701445145317456751
- FanQWWeissWATargeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistanceCurr Top Microbiol Immunol201034727929620535652
- HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med2005352997100315758010
- HainsworthJDShihKCShepardGCTillinghastGWBrinkerBTSpigelDRPhase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastomaClin Adv Hematol Oncol20121024024622706484
- HegiMEDiserensACBadyPPathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib – a phase II trialMol Cancer Ther2011101102111221471286
- KreislTNSmithPSulJContinuous daily sunitinib for recurrent glioblastomaJ Neurooncol2013111414823086433
- ReardonDAVredenburghJJCoanAPhase I study of sunitinib and irinotecan for patients with recurrent malignant gliomaJ Neurooncol201110562162721744079
- AliSCurtinJFZirgerJMInflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progressionMol Ther2004101071108415564139
- AliSKingGDCurtinJFCombined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma modelCancer Res2005657194720416103070
- Ghulam MuhammadAKCandolfiMKingGDAntiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regressionClin Cancer Res2009156113612719789315
- KingGDMuhammadAKCurtinJFFlt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma modelNeuro Oncol200810193118079358
- HurttMRMoossyJDonovan-PelusoMLockerJAmplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosisJ Neuropathol Exp Neurol19925184901311022
- NishikawaRJiXDHarmonRCA mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicityProc Natl Acad Sci U S A199491772777318052651
- AkhavanDCloughesyTFMischelPSmTOR signaling in glioblastoma: lessons learned from bench to bedsideNeuro Oncol20101288288920472883
- HuangHSNaganeMKlingbeilCKThe enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signalingJ Biol Chem1997272292729359006938
- MellinghoffIKWangMYVivancoIMolecular determinants of the response of glioblastomas to EGFR kinase inhibitorsN Engl J Med20053532012202416282176
- GillilandDGGriffinJDRole of FLT3 in leukemiaCurr Opin Hematol2002927428112042700
- NakaoMYokotaSIwaiTInternal tandem duplication of the flt3 gene found in acute myeloid leukemiaLeukemia199610191119188946930
- WeisbergESattlerMRayAGriffinJDDrug resistance in mutant FLT3-positive AMLOncogene2010295120513420622902